Fisher & Paykel Healthcare Corporation Limited announced that Lisa McIntyre, PhD, has been appointed as a non-executive director of the company with effect from 1 October 2021. Dr. McIntyre is an experienced company director with a broad portfolio that spans the health care, insurance, technology and e-learning sectors. She is currently a non-executive director of Insurance and Care NSW (a government public financial corporation), HCF Group (a private health insurance company in Australia), The University of Sydney, Studiosity and Nanosonics, and chair of LEK Consulting's ANZ Advisory Board. The Fisher & Paykel Healthcare Board has determined that Dr. McIntyre will be an independent director of the Board. She will also serve as a member of the Quality, Safety and Regulatory Committee, effective 1 October 2021. A resolution to elect Dr. McIntyre will be put to shareholders at the company's next annual shareholders' meeting in August 2022. Dr. McIntyre replaces Tony Carter, who retired from the Board in August 2020.